Clinical trials will be carried out in the UK to verify the safety and effectiveness of two new coronal vaccines under development by injecting them into the respiratory tract.
Imperial College London said in a statement 14, the test personnel will spray the vaccine into the subjects’ mouth, directly acting on the respiratory tract, testing the safety and effectiveness.
Christopher Qiu, an expert in the Department of infectious diseases at Imperial College of technology, who presided over the inhalation clinical trial, said that the influenza vaccine injected from the nasal cavity has been proved to be effective, so it is necessary to study whether the new coronal vaccine can also work directly on the respiratory tract.
the statement said that compared with the systemic immune response induced by intramuscular injection, the injection of new crown vaccine into the respiratory tract may trigger local and more specific immune response. In addition, according to previous studies, the dose of the vaccine required to trigger the immune response is smaller for inhalation than for intramuscular injection.
researchers are recruiting 30 healthy volunteers aged 18 to 55. The trial is due to begin in London in a few weeks. Pigtail is the most delicious way to do, super simple, women often eat, beauty and beauty, delay aging